NCT02229396 · Interventional trial
Phase 3 28-Week Study With 24-Week and 52-week Extension Phases to Evaluate Efficacy and Safety of Exenatide Once Weekly and Dapagliflozin Versus Exenatide and Dapagliflozin Matching Placebo
Overall registry status Completed
Phase 3
Conditions Diabetes Mellitus
Delaware Valley sites
- Research Site · Haddon Heights, NJ · Camden County
First posted
Registry updated
Added to the directory